FluiDx-AD
@fluidx-ad.bsky.social
We are an #H2020 funded research project coordinated by Oslo University Hospital.
Our mission is to develop a novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's disease.
Our mission is to develop a novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's disease.
Members of the @fluidx-ad.bsky.social projects' Advisory Board held their first online meeting.
FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease diagnosis & management through the development of innovative saliva and blood-based tests.
www.fluidx-ad.eu/members-of-t...
FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease diagnosis & management through the development of innovative saliva and blood-based tests.
www.fluidx-ad.eu/members-of-t...
Members of the FluiDx-AD Public Advisory Board meet online - FluiDx-AD
FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease (AD) diagnosis and management through the development of innovative saliva and blood-based diagnostic tests. These tests wil...
www.fluidx-ad.eu
December 8, 2025 at 7:27 AM
Members of the @fluidx-ad.bsky.social projects' Advisory Board held their first online meeting.
FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease diagnosis & management through the development of innovative saliva and blood-based tests.
www.fluidx-ad.eu/members-of-t...
FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease diagnosis & management through the development of innovative saliva and blood-based tests.
www.fluidx-ad.eu/members-of-t...
Yesterday, project partners Faye Forsyth & @chrisbintener.bsky.social met with members of @alzheimereurope.bsky.social European Working Group of People with Dementia to discuss how to implement feedback on a saliva sample collection procedure to screen for #Alzheimer’s disease biomarkers. #EWGPWD
November 27, 2025 at 7:19 AM
Yesterday, project partners Faye Forsyth & @chrisbintener.bsky.social met with members of @alzheimereurope.bsky.social European Working Group of People with Dementia to discuss how to implement feedback on a saliva sample collection procedure to screen for #Alzheimer’s disease biomarkers. #EWGPWD
Reposted by FluiDx-AD
Today, Faye Forsyth & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimer’s disease biomarkers in saliva.
Next week we’ll focus on how to communicate test results with potential future users: fluidx-ad.eu
Next week we’ll focus on how to communicate test results with potential future users: fluidx-ad.eu
November 20, 2025 at 12:54 PM
Today, Faye Forsyth & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimer’s disease biomarkers in saliva.
Next week we’ll focus on how to communicate test results with potential future users: fluidx-ad.eu
Next week we’ll focus on how to communicate test results with potential future users: fluidx-ad.eu
Have a read of @alzheimereurope.bsky.social newsletter, featuring the first #H2020 @fluidx-ad.bsky.social General Assembly & a consultation with the European Working Group of People with Dementia & European Dementia Carers Working Group on a saliva prototype for Alzheimer’s disease biomarkers.
Check out our October #dementia newsletter, with some spookily good articles to capture your interest this #Halloween!
Highlights include:
News from #35AEC
The latest #DementiainEurope magazine plus its supplement on #BrainHealth
#AEAntiStigmaAward news
bit.ly/AE-newslette...
Highlights include:
News from #35AEC
The latest #DementiainEurope magazine plus its supplement on #BrainHealth
#AEAntiStigmaAward news
bit.ly/AE-newslette...
November 3, 2025 at 7:32 AM
Have a read of @alzheimereurope.bsky.social newsletter, featuring the first #H2020 @fluidx-ad.bsky.social General Assembly & a consultation with the European Working Group of People with Dementia & European Dementia Carers Working Group on a saliva prototype for Alzheimer’s disease biomarkers.
HemoDx, is developing a saliva collection device that could enable cheaper and easier screening for #Alzheimer’s disease.
Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations.
www.fluidx-ad.eu/fluidx-ad-co...
Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations.
www.fluidx-ad.eu/fluidx-ad-co...
FluiDx-AD consults with people affected by dementia to improve screening test - FluiDx-AD
Background HemoDx, a Norwegian company, have developed a saliva collection device and kit to obtain and transport dried saliva samples cheaply and safely. The device consists of a special paper-based ...
www.fluidx-ad.eu
October 20, 2025 at 8:02 AM
HemoDx, is developing a saliva collection device that could enable cheaper and easier screening for #Alzheimer’s disease.
Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations.
www.fluidx-ad.eu/fluidx-ad-co...
Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations.
www.fluidx-ad.eu/fluidx-ad-co...
The @fluidx-ad.bsky.social consortium met in Bologna to review progress and plan next steps in developing saliva, plasma and blood tests to improve early diagnosis & management of #Alzheimer’s disease.
Read more: www.fluidx-ad.eu/fluidx-ad-co...
Read more: www.fluidx-ad.eu/fluidx-ad-co...
FluiDx-AD consortium meets in Bologna to review progress and plan next steps - FluiDx-AD
On 9 October 2025, the FluiDx-AD consortium held its General Assembly meeting in Bologna, Italy. The FluiDx-AD project, funded by the European Union’s Horizon Europe programme with a budget of EUR 7,6...
www.fluidx-ad.eu
October 20, 2025 at 7:30 AM
The @fluidx-ad.bsky.social consortium met in Bologna to review progress and plan next steps in developing saliva, plasma and blood tests to improve early diagnosis & management of #Alzheimer’s disease.
Read more: www.fluidx-ad.eu/fluidx-ad-co...
Read more: www.fluidx-ad.eu/fluidx-ad-co...
Ahead of @alzheimereurope.bsky.social #35AEC Bologna: members of the European Working Group of People with Dementia & the European Dementia Carers Working Group are consulting on @fluidx-ad.bsky.social prototype saliva-based screening tests for Alzheimer’s disease risk indication.
www.fluidx-ad.eu
www.fluidx-ad.eu
October 6, 2025 at 9:01 AM
Ahead of @alzheimereurope.bsky.social #35AEC Bologna: members of the European Working Group of People with Dementia & the European Dementia Carers Working Group are consulting on @fluidx-ad.bsky.social prototype saliva-based screening tests for Alzheimer’s disease risk indication.
www.fluidx-ad.eu
www.fluidx-ad.eu
Anti-amyloid therapies cause ARIA in a subset of patients. We are working on blood-based biomarkers & a whole-blood ex vivo assay to help identify who may benefit and who may be at higher risk, supporting eligibility assessment & monitoring.
www.fluidx-ad.eu #WorldAlzMonth #WAM2025
www.fluidx-ad.eu #WorldAlzMonth #WAM2025
September 19, 2025 at 5:32 AM
Anti-amyloid therapies cause ARIA in a subset of patients. We are working on blood-based biomarkers & a whole-blood ex vivo assay to help identify who may benefit and who may be at higher risk, supporting eligibility assessment & monitoring.
www.fluidx-ad.eu #WorldAlzMonth #WAM2025
www.fluidx-ad.eu #WorldAlzMonth #WAM2025
Accessible, low-burden testing matters. FluiDx-AD is working towards validation of saliva and plasma biomarkers as well as automated workflows that fit routine clinics, with documentation to support future regulatory steps. www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
#WorldAlzMonth #WAM2025
September 18, 2025 at 5:27 AM
Accessible, low-burden testing matters. FluiDx-AD is working towards validation of saliva and plasma biomarkers as well as automated workflows that fit routine clinics, with documentation to support future regulatory steps. www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
#WorldAlzMonth #WAM2025
“Low-cost & simple” matters when you are waiting for answers. Earlier diagnosis helps people plan, seek support, and know what to expect. We aim to evaluate a three-test approach using saliva & blood biomarkers to support earlier, reliable decisions.
#WorldAlzMonth #WAM2025 www.fluidx-ad.eu
#WorldAlzMonth #WAM2025 www.fluidx-ad.eu
September 17, 2025 at 8:31 AM
“Low-cost & simple” matters when you are waiting for answers. Earlier diagnosis helps people plan, seek support, and know what to expect. We aim to evaluate a three-test approach using saliva & blood biomarkers to support earlier, reliable decisions.
#WorldAlzMonth #WAM2025 www.fluidx-ad.eu
#WorldAlzMonth #WAM2025 www.fluidx-ad.eu
Early answers open access to support. FluiDx-AD aims to develop and validate three complementary tests: saliva risk indication, plasma confirmation, and a whole blood ex-vivo assay for ARIA risk to guide therapy decisions. #WorldAlzMonth #WAM2025 #WorldAlzheimersMonth
www.fluidx-ad.eu
www.fluidx-ad.eu
September 16, 2025 at 7:38 AM
Early answers open access to support. FluiDx-AD aims to develop and validate three complementary tests: saliva risk indication, plasma confirmation, and a whole blood ex-vivo assay for ARIA risk to guide therapy decisions. #WorldAlzMonth #WAM2025 #WorldAlzheimersMonth
www.fluidx-ad.eu
www.fluidx-ad.eu
Early, reliable answers help families plan.
FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
September 15, 2025 at 7:07 AM
Early, reliable answers help families plan.
FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
In FluiDx-AD, we aim to develop & validate a trio of saliva- and blood-based tests to support earlier detection, precise confirmation, and ARIA risk assessment for therapy decisions. More information: www.fluidx-ad.eu
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
September 12, 2025 at 8:04 AM
In FluiDx-AD, we aim to develop & validate a trio of saliva- and blood-based tests to support earlier detection, precise confirmation, and ARIA risk assessment for therapy decisions. More information: www.fluidx-ad.eu
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
People may have to wait far too long for an Alzheimer’s disease diagnosis.
FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
September 11, 2025 at 7:52 AM
People may have to wait far too long for an Alzheimer’s disease diagnosis.
FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
🧠On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimer’s diagnosis with saliva & blood-based tests.
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD
FluiDx-AD - A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of AD
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily re flect those of the European Union. Neither…
vimeo.com
July 22, 2025 at 9:48 AM
🧠On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimer’s diagnosis with saliva & blood-based tests.
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD
The AI-Mind project builds AI tools to scan brain connectivity and predict dementia risk, giving clinicians earlier insight.
Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement
www.alzheimer-europe.org/sites/defaul...
Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement
www.alzheimer-europe.org/sites/defaul...
www.alzheimer-europe.org
June 3, 2025 at 9:44 AM
The AI-Mind project builds AI tools to scan brain connectivity and predict dementia risk, giving clinicians earlier insight.
Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement
www.alzheimer-europe.org/sites/defaul...
Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement
www.alzheimer-europe.org/sites/defaul...
Reposted by FluiDx-AD
Survey Study Aims to Assess Germany’s Readiness for Early #Alzheimer Diagnosis Using Biomarkers #ADPD2025
👉 www.neurologylive.com/view/survey-...
👉 www.neurologylive.com/view/survey-...
Survey Study Aims to Assess Germany’s Readiness for Early Alzheimer Diagnosis Using Biomarkers
A new survey study will assess how well German memory clinics and specialists are equipped to provide early and accurate Alzheimer diagnoses using biomarker-based methods.
www.neurologylive.com
April 4, 2025 at 5:58 AM
Survey Study Aims to Assess Germany’s Readiness for Early #Alzheimer Diagnosis Using Biomarkers #ADPD2025
👉 www.neurologylive.com/view/survey-...
👉 www.neurologylive.com/view/survey-...
A new study shows a saliva test outperforms current blood tests in predicting prostate cancer risk.
@fluidx-ad.bsky.social aims to do the same for #Alzheimer’s, with SalivaDx-AD enabling easy at-home risk detection.
www.alzheimer-europe.org/our-work/cur...
www.theguardian.com/society/2025...
@fluidx-ad.bsky.social aims to do the same for #Alzheimer’s, with SalivaDx-AD enabling easy at-home risk detection.
www.alzheimer-europe.org/our-work/cur...
www.theguardian.com/society/2025...
At-home saliva test for prostate cancer better than blood test, study suggests
Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening
www.theguardian.com
April 10, 2025 at 10:46 AM
A new study shows a saliva test outperforms current blood tests in predicting prostate cancer risk.
@fluidx-ad.bsky.social aims to do the same for #Alzheimer’s, with SalivaDx-AD enabling easy at-home risk detection.
www.alzheimer-europe.org/our-work/cur...
www.theguardian.com/society/2025...
@fluidx-ad.bsky.social aims to do the same for #Alzheimer’s, with SalivaDx-AD enabling easy at-home risk detection.
www.alzheimer-europe.org/our-work/cur...
www.theguardian.com/society/2025...
A big thank you to @geriatricarea.bsky.social, who shared our press release about the launch of @fluidx-ad.bsky.social in their news coverage!
Link (in Spanish!) below ⏬
www.geriatricarea.com/2025/04/03/e...
Link (in Spanish!) below ⏬
www.geriatricarea.com/2025/04/03/e...
El proyecto FluiDx-AD busca mejorar el diagnóstico del Alzheimer
El proyecto FluiDx-AD busca pruebas clínicas para mejorar el diagnóstico precoz y la gestión de la enfermedad de Alzheimer
www.geriatricarea.com
April 4, 2025 at 7:50 AM
A big thank you to @geriatricarea.bsky.social, who shared our press release about the launch of @fluidx-ad.bsky.social in their news coverage!
Link (in Spanish!) below ⏬
www.geriatricarea.com/2025/04/03/e...
Link (in Spanish!) below ⏬
www.geriatricarea.com/2025/04/03/e...
The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease ⤵️
www.alzheimer-europe.org/sites/defaul...
www.alzheimer-europe.org/sites/defaul...
March 17, 2025 at 8:37 AM
The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease ⤵️
www.alzheimer-europe.org/sites/defaul...
www.alzheimer-europe.org/sites/defaul...
@fluidx-ad.bsky.social is set to improve #Alzheimer’s disease diagnosis with minimally invasive, cost-effective saliva & blood tests.
Learn more: alzheimereurope.newsweaver.com/ConferenceAn...
www.vimeo.com/1058971988
Learn more: alzheimereurope.newsweaver.com/ConferenceAn...
www.vimeo.com/1058971988
March 5, 2025 at 9:39 AM
@fluidx-ad.bsky.social is set to improve #Alzheimer’s disease diagnosis with minimally invasive, cost-effective saliva & blood tests.
Learn more: alzheimereurope.newsweaver.com/ConferenceAn...
www.vimeo.com/1058971988
Learn more: alzheimereurope.newsweaver.com/ConferenceAn...
www.vimeo.com/1058971988